STEMI Versus NSTEMI: Clinical and Angiographic Differences

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-01-31

Study Completion Date

2012-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess differences in the risk profile and in the coronary angiographic presentation between STEMI and NSTEMI. Moreover possible relationship between myocardial infarction presentation and renal function will be investigated.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Initial CT Perfusion-Guided Strategy for Suspected NSTEMI

NCT06689267

Non-ST Elevation Myocardial Infarction

RECRUITING NA

Clinical Presentations Before AMI Onset and Coronary Atherosclerosis

NCT03107624

Acute Myocardial Infarction

COMPLETED

Myocardial Contrast Echocardiography for the Assessment of the Infarct Related Artery & Risk Area in Patients w/ NSTEMI.

NCT02014701

STEMI

UNKNOWN NA

Coronary Arteriosclerosis in Patients With Acute Ischemic Stroke

NCT00701818

Ischemic Stroke Myocardial Ischemia Coronary Arteriosclerosis

COMPLETED

Clinical Risk Score Predicting the Cardiac Rupture in Patients With ST-elevation Myocardial Infarction

NCT02484326

Cardiac Rupture

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Assessment of risk profile. Diabetes mellitus diagnosed when fasting blood glucose (FBG) was \>= 126mg/dL or if patients were taking oral hypoglycaemic drugs or were on insulin treatment. Hypertension defined as blood pressure \>= 140/90 mmHg or history of antihypertensive treatment. Hypercholesterolemia,adjudicated when cholesterol levels were \>= 200 mg/dL or with patients on lipid lowering treatment. Hypertriglyceridemia adjudicated on fasting triglyceride levels\>= 200 mg/dL or triglyceride-lowering therapy . Obesity, defined as BMI \>= 30 kg/m2.

Patients with STEMI, who had not been previously treated with thrombolysis, and those who had been undergone to an unsuccessful thrombolysis, as well as patients with NSTEMI with a TIMI score\> 3 who were immediately referred to the Cat Lab and whenever possible treated with PTCA and stenting of the culprit lesion. The other patients who were referred to Cat Lab within 48 hours from the beginning of chest pain, unless their general conditions did not strongly suggest to delay the procedure after 2 more days.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Coronary Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients admitted in the coronary care unit (CCU) of the Department of Clinical and Experimental Medicine at the Federico 2nd University Hospital;
* Patient with indication to angiographic study even if not immediately;
* Patients referred to CCU with the diagnosis of acute myocardial infraction (AMI), type STEMI, or NSTEMI, based on pre-admission assessment of troponin I (TpI) and myocardial band creatin kinase (CK-MB;
* Diagnosis of NSTEMI/STEMI performed according to standard criteria